178 related articles for article (PubMed ID: 8458338)
1. In vivo inhibition of duck hepatitis B virus replication and gene expression by phosphorothioate modified antisense oligodeoxynucleotides.
Offensperger WB; Offensperger S; Walter E; Teubner K; Igloi G; Blum HE; Gerok W
EMBO J; 1993 Mar; 12(3):1257-62. PubMed ID: 8458338
[TBL] [Abstract][Full Text] [Related]
2. [Inhibition of duck hepatitis B virus DNA replication by antisense phosphorothioate oligodeoxynucleotides in vitro and in vivo].
Dong B; Shao XW; Tao PZ
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Mar; 17(1):25-7. PubMed ID: 12870012
[TBL] [Abstract][Full Text] [Related]
3. Antisense therapy of hepatitis B virus infection.
Offensperger WB; Offensperger S; Blum HE
Mol Biotechnol; 1998 Apr; 9(2):161-70. PubMed ID: 9658393
[TBL] [Abstract][Full Text] [Related]
4. Biodistribution, stability, and antiviral efficacy of liposome-entrapped phosphorothioate antisense oligodeoxynucleotides in ducks for the treatment of chronic duck hepatitis B virus infection.
Soni PN; Brown D; Saffie R; Savage K; Moore D; Gregoriadis G; Dusheiko GM
Hepatology; 1998 Nov; 28(5):1402-10. PubMed ID: 9794928
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of duck hepatitis B virus replication by intrahepatic expression of an antiviral resistance gene.
Kündgen LR; Thoma C; Köck J; Wilting J; Koch K; Offensperger WB; Blum HE; von Weizsäcker F
J Mol Med (Berl); 2002 Mar; 80(3):187-95. PubMed ID: 11894145
[TBL] [Abstract][Full Text] [Related]
6. In vivo inhibition of hepatitis B virus gene expression by antisense phosphorothioate oligonucleotides.
Moriya K; Matsukura M; Kurokawa K; Koike K
Biochem Biophys Res Commun; 1996 Jan; 218(1):217-23. PubMed ID: 8573134
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of duck hepatitis B virus replication by 2',3'-dideoxy-3'-fluoroguanosine in vitro and in vivo.
Hafkemeyer P; Keppler-Hafkemeyer A; al Haya MA; von Janta-Lipinski M; Matthes E; Lehmann C; Offensperger WB; Offensperger S; Gerok W; Blum HE
Antimicrob Agents Chemother; 1996 Mar; 40(3):792-4. PubMed ID: 8851615
[TBL] [Abstract][Full Text] [Related]
8. [Antisense oligodeoxynucleotide targeted at the pre-s region of DHBV could inhibit virus replication in vivo].
He L; Wu X; Chen C
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Mar; 12(1):1-4. PubMed ID: 12515159
[TBL] [Abstract][Full Text] [Related]
9. Protective efficacy of DNA vaccines against duck hepatitis B virus infection.
Triyatni M; Jilbert AR; Qiao M; Miller DS; Burrell CJ
J Virol; 1998 Jan; 72(1):84-94. PubMed ID: 9420203
[TBL] [Abstract][Full Text] [Related]
10. Antiviral strategies in chronic hepatitis B virus infection: II. Inhibition of duck hepatitis B virus in vitro using conventional antiviral agents and supercoiled-DNA active compounds.
Civitico G; Wang YY; Luscombe C; Bishop N; Tachedjian G; Gust I; Locarnini S
J Med Virol; 1990 Jun; 31(2):90-7. PubMed ID: 1696959
[TBL] [Abstract][Full Text] [Related]
11. Specific inhibition of hepatitis C viral gene expression by antisense phosphorothioate oligodeoxynucleotides.
Alt M; Renz R; Hofschneider PH; Paumgartner G; Caselmann WH
Hepatology; 1995 Sep; 22(3):707-17. PubMed ID: 7657273
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of hepadnaviral replication by polyethylenimine-based intravenous delivery of antisense phosphodiester oligodeoxynucleotides to the liver.
Robaczewska M; Guerret S; Remy JS; Chemin I; Offensperger WB; Chevallier M; Behr JP; Podhajska AJ; Blum HE; Trepo C; Cova L
Gene Ther; 2001 Jun; 8(11):874-81. PubMed ID: 11423935
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of 9-(2-phosphonylmethoxyethyl)-adenine (PMEA) on human and duck hepatitis B virus infection.
Heijtink RA; De Wilde GA; Kruining J; Berk L; Balzarini J; De Clercq E; Holy A; Schalm SW
Antiviral Res; 1993 Jun; 21(2):141-53. PubMed ID: 8338351
[TBL] [Abstract][Full Text] [Related]
14. Duck hepatitis B virus infection of Muscovy duck hepatocytes and nature of virus resistance in vivo.
Pugh JC; Simmons H
J Virol; 1994 Apr; 68(4):2487-94. PubMed ID: 7511172
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a 120-Kilodalton pre-S-binding protein as a candidate duck hepatitis B virus receptor.
Li JS; Tong SP; Wands JR
J Virol; 1996 Sep; 70(9):6029-35. PubMed ID: 8709225
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of duck hepatitis B virus replication by 2',3'-dideoxycytidine. A potent inhibitor of reverse transcriptase.
Kassianides C; Hoofnagle JH; Miller RH; Doo E; Ford H; Broder S; Mitsuya H
Gastroenterology; 1989 Nov; 97(5):1275-80. PubMed ID: 2477299
[TBL] [Abstract][Full Text] [Related]
17. Effects of 2'-fluorinated arabinosyl-pyrimidine nucleosides on duck hepatitis B virus DNA level in serum and liver of chronically infected ducks.
Fourel I; Li J; Hantz O; Jacquet C; Fox JJ; Trépo C
J Med Virol; 1992 Jun; 37(2):122-6. PubMed ID: 1629711
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of human and duck hepatitis B virus by 2',3'-dideoxy-3'-fluoroguanosine in vitro.
Schröder I; Holmgren B; Oberg M; Löfgren B
Antiviral Res; 1998 Jan; 37(1):57-66. PubMed ID: 9497073
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of duck hepatitis B virus infection of liver cells by combined treatment with viral e antigen and carbohydrates.
Maenz C; Loscher C; Iwanski A; Bruns M
J Gen Virol; 2008 Dec; 89(Pt 12):3016-3026. PubMed ID: 19008388
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of hepatitis B viral gene expression by antisense phosphorothioate oligodeoxynucleotides.
Yao ZQ; Zhou YX; Wang AL; Bai XF; Yang WS
J Viral Hepat; 1995; 2(2):85-9. PubMed ID: 7493302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
